Hyperuricemia in congenital heart disease

Area of Science:

• Cardiology
• Nephrology
• Genetics

Background:

• Gout is infrequently associated with secondary polycythemia.
• Congenital heart disease, particularly cyanotic types, can cause profound polycythemia.
• The relationship between polycythemia in congenital heart disease and hyperuricemia is not well-established.

Purpose of the Study:

• To determine the incidence of hyperuricemia in patients with congenital heart disease.
• To investigate the correlation between serum uric acid levels and the degree of polycythemia.
• To assess the potential risk of uric acid nephropathy in this patient population.

Main Methods:

• Retrospective study of 81 patients with congenital heart disease.
• Serum uric acid levels were measured.
• Correlation analysis was performed between uric acid levels and polycythemia severity.

Main Results:

• Twenty of 46 patients (43%) with cyanotic congenital heart disease exhibited hyperuricemia (serum uric acid > 8 mg/dl).
• Hyperuricemia was more prevalent in older cyanotic males (81% in those >15 years).
• Serum uric acid levels showed a direct correlation with the degree of polycythemia (r = .44, P < .02).

Conclusions:

• Hyperuricemia is a significant clinical issue in cyanotic congenital heart disease.
• The degree of polycythemia is directly associated with elevated uric acid levels.
• A substantial number of these patients may be at risk for subclinical uric acid nephropathy.